Product Type: | Injection |
Brand Name: | Reliance Life Sciences |
Packaging Type | Box |
Packaging: | 10 ml |
Composition / Material Type: | 15 g |
Usages: | Inject |
AzatiRel ™ (Azacitidine for Injection) contains Azacitidine IP, which is a pyrimidine Nucleoside analog of cytidine. Azacitidine is believed to exert its antineoplastic effects by causing hypomethylation of DNA and direct cytotoxicity on abnormal hematopoietic cells in the bone marrow.
Azacitidine is indicated for treatment of patients with the following French-American- British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).